Company / Interest Expense
Fulgent Genetics, Inc. Interest Expense History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$20.0K
FY2022
5-year range
$20.0K / $20.0K
FY2020-FY2022
Trend
+0.0%
vs FY2021
Sector context
#44 of 43
Health Care
What the data says
Among 43 Health Care companies, Fulgent Genetics, Inc. is in the top -2% for interest expense. Interest Expense remained relatively stable over the past 3 years, with values between $20,000 and $20,000.
Based on SEC 10-K filings.
$20,000 in FY2022.
Remained stable around $20,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 43This company $20.0K Sector average $324.8M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2022, interest expense increased 0.0% year-over-year.
- Ranks #44 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $20.0K | +0.0% |
| FY2021 | $20.0K | +0.0% |
| FY2020 | $20.0K | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026